,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-01-05 05:31:00,Johnson & Johnson (NYSE: JNJ ) has remained a long-time favorite among conservative investors.,0.4467022120952606,0.020483363419771194,0.5328144431114197,neutral,0.42621883749961853
1,2018-01-05 05:31:00,"Its production of necessary, recession-proof products as well as its consistent dividend have provided comfortable, consistent profits for decades.",0.8971400856971741,0.012874686159193516,0.08998526632785797,positive,0.8842654228210449
2,2018-01-05 05:31:00,A large increase in 2017 has taken the healthcare giant to an average valuation.,0.9200157523155212,0.01447902712970972,0.0655052661895752,positive,0.9055367112159729
3,2018-01-05 05:31:00,"However, given the high earnings growth, JNJ stock remains well-positioned to continue its march higher.",0.9522905945777893,0.023150097578763962,0.02455933392047882,positive,0.9291405081748962
4,2018-01-05 05:31:00,One is hard-pressed to find many negatives about Johnson & Johnson stock.,0.025133663788437843,0.5777456760406494,0.3971206545829773,negative,-0.5526120066642761
5,2018-01-05 05:31:00,"Of all the stocks traded today, few have enjoyed so much cash flow, so consistently, for so long as Johnson & Johnson.",0.3103804886341095,0.024275461211800575,0.6653439998626709,neutral,0.28610503673553467
6,2018-01-05 05:31:00,"This equity holds its place among so-called ""dividend aristocrats.""",0.16425958275794983,0.015940556302666664,0.8197999000549316,neutral,0.14831902086734772
7,2018-01-05 05:31:00,These are S&P 500 index stocks that have a 25+-year record of annual dividend increases.,0.24225376546382904,0.009551925584673882,0.7481943368911743,neutral,0.23270183801651
8,2018-01-05 05:31:00,JNJ's has increased its dividend every year for 55 years.,0.9019439220428467,0.01569199562072754,0.08236408978700638,positive,0.8862519264221191
9,2018-01-05 05:31:00,"Right now, the company pays a dividend yield of about 2.4%.",0.02248363010585308,0.008852199651300907,0.9686641097068787,neutral,0.013631430454552174
10,2018-01-05 05:31:00,"The dividend currently stands at $3.36 per share, which was the stock's approximate split-adjusted price in 1986.",0.03453846648335457,0.016872016713023186,0.948589563369751,neutral,0.017666449770331383
11,2018-01-05 05:31:00,Most investors know JNJ best for its consumer products that have been found in most of America's medicine cabinets for more than 100 years.,0.14989636838436127,0.008465924300253391,0.8416376709938049,neutral,0.14143043756484985
12,2018-01-05 05:31:00,"However, unlike Procter & Gamble Co (NYSE: PG ), consumer products make up a small segment of the company's business.",0.009935276582837105,0.01455285120755434,0.9755118489265442,neutral,-0.0046175746247172356
13,2018-01-05 05:31:00,"Like Merck & Co., Inc. (NYSE: MRK ) or Eli Lilly and Co (NYSE: LLY ), most of the growth comes from drug sales.",0.18513624370098114,0.006423856597393751,0.8084399104118347,neutral,0.1787123829126358
14,2018-01-05 05:31:00,It is this growth that has propelled the stock to new all-time highs.,0.8870985507965088,0.016531797125935555,0.0963696539402008,positive,0.870566725730896
15,2018-01-05 05:31:00,The stock has risen by about 27% over the last 12 months.,0.9391103386878967,0.0169968381524086,0.043892815709114075,positive,0.9221134781837463
16,2018-01-05 05:31:00,This level of growth might discourage more risk-averse investors.,0.49717435240745544,0.3036174476146698,0.19920818507671356,positive,0.19355690479278564
17,2018-01-05 05:31:00,I believe Johnson & Johnson stock has more room to grow in the near term.,0.919691264629364,0.012638448737561703,0.06767022609710693,positive,0.9070528149604797
18,2018-01-05 05:31:00,"Currently, the JNJ stock price stands at around $140 per share.",0.027496617287397385,0.0072789439000189304,0.9652243852615356,neutral,0.02021767385303974
19,2018-01-05 05:31:00,This places the price-to-earnings (PE) ratio at around 24.3.,0.050329700112342834,0.008852647617459297,0.940817654132843,neutral,0.041477054357528687
20,2018-01-05 05:31:00,This is near the S&P 500 's current average PE of 23.6.,0.22678230702877045,0.20374560356140137,0.5694721341133118,neutral,0.02303670346736908
21,2018-01-05 05:31:00,"However, Johnson & Johnson stock maintained double-digit earnings growth at the beginning of the decade.",0.9464389085769653,0.01716952957212925,0.03639163449406624,positive,0.9292693734169006
22,2018-01-05 05:31:00,This growth paused in 2015 before returning to the single digits.,0.1458432376384735,0.09558358788490295,0.7585731744766235,neutral,0.05025964975357056
23,2018-01-05 05:31:00,"With earnings of $7.28 per share expected for fiscal 2017, Johnson & Johnson stock is expected to maintain a single-digit earnings growth rate for the next three years.",0.9467223882675171,0.015280380845069885,0.03799720108509064,positive,0.9314420223236084
24,2018-01-05 05:31:00,"Also, demographics create a favorable environment for JNJ stock.",0.8174203634262085,0.013236773200333118,0.1693428009748459,positive,0.8041836023330688
25,2018-01-05 05:31:00,"At its core, Johnson & Johnson's main business remains healthcare.",0.023760057985782623,0.0050455196760594845,0.9711943864822388,neutral,0.01871453784406185
26,2018-01-05 05:31:00,The baby boom population currently stands at about 74.9 million people.,0.04188576340675354,0.009930616244673729,0.9481835961341858,neutral,0.03195514529943466
27,2018-01-05 05:31:00,This cohort continues to age into Medicare at a record pace.,0.8112936615943909,0.013101422227919102,0.17560485005378723,positive,0.7981922626495361
28,2018-01-05 05:31:00,"Forbes estimates 10,000 people per day age into Medicare .",0.18585079908370972,0.03304661810398102,0.7811025381088257,neutral,0.1528041809797287
29,2018-01-05 05:31:00,These baby boomers will use the same consumer healthcare products with which they've known all of their lives.,0.07767324149608612,0.005404498893767595,0.9169222712516785,neutral,0.07226873934268951
30,2018-01-05 05:31:00,"Moreover, many of the company's medical devices and drugs cater to baby boomers.",0.09405777603387833,0.004954847041517496,0.9009873867034912,neutral,0.08910293132066727
31,2018-01-05 05:31:00,"JNJ produces medical devices in the areas of heart surgery and diabetes care, among others.",0.04416719451546669,0.004477229900658131,0.9513555765151978,neutral,0.039689965546131134
32,2018-01-05 05:31:00,"They also manufacture drugs for the treatment of rheumatoid arthritis, Crohn's disease, and several cancers.",0.026872195303440094,0.006190370302647352,0.9669374823570251,neutral,0.020681824535131454
33,2018-01-05 05:31:00,Coverage by Medicare will make the devices and drugs affordable to consumers and profitable for Johnson & Johnson stock investors.,0.8747920989990234,0.013264408335089684,0.11194350570440292,positive,0.861527681350708
34,2018-01-05 05:31:00,"Despite strong growth in 2017 and a conservative outlook, conditions still position Johnson & Johnson stock to move higher.",0.9383180141448975,0.03109000064432621,0.030592050403356552,positive,0.9072279930114746
35,2018-01-05 05:31:00,"While it's true that the stock rose by 27% over the last 12 months, many growth catalysts still exist in this equity.",0.9139798879623413,0.015801789239048958,0.07021822035312653,positive,0.8981781005859375
36,2018-01-05 05:31:00,Population growth and especially growth with the large numbers of baby boomers aging into Medicare should benefit Johnson & Johnson.,0.8441590666770935,0.012795686721801758,0.14304517209529877,positive,0.8313633799552917
37,2018-01-05 05:31:00,"At 2.4%, the current dividend yield remains lower than some high-flyers.",0.020577333867549896,0.9616578817367554,0.017764713615179062,negative,-0.9410805702209473
38,2018-01-05 05:31:00,"However, that dividend has a track record of dividend increases that spans over 55 years.",0.8715919256210327,0.013224167749285698,0.11518379300832748,positive,0.8583677411079407
39,2018-01-05 05:31:00,"Further, growth should push the PE ratio lower as staying in the stock allows investors to receive higher dividends.",0.6679034233093262,0.256384938955307,0.07571165263652802,positive,0.41151848435401917
40,2018-01-05 05:31:00,"If one wants a steady stream of cash flow and a strong, consistent dividend, JNJ stock remains a great choice for the conservative investor.",0.8196110129356384,0.014892149716615677,0.165496826171875,positive,0.8047188520431519
41,2018-01-05 05:31:00,"As of this writing, Will Healy did not hold a position in any of the aforementioned stocks.",0.007885388098657131,0.023561477661132812,0.9685531854629517,neutral,-0.015676088631153107
42,2018-01-05 05:31:00,"• 9 More Companies Whose Dividend Is in Danger
• 7 Emerging Market ETFs to Buy for Big Gains in 2018

The post The Slow Push Upward Continues for Johnson & Johnson Stock appeared first on InvestorPlace .",0.7705530524253845,0.07081597298383713,0.15863099694252014,positive,0.6997370719909668
43,2018-01-05 05:31:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
